Trademarkia Logo

Australia

AU$
GVOKE VIALDX
Protected: Registered/protected

Last updated on 25 Jun 2024

Owner Info

Xeris Pharmaceuticals, Inc.

180 N LaSalle Street, Suite 1810

Chicago IL 60601, UNITED STATES OF AMERICA

Serial Number

2442128 filed on 9 Feb 2024

Correspondent

Tracy-Gene G. Durkin Sterne, Kessler, Goldstein & Fox P.L.L.C.

1101 K Street, NW, 10th Floor,

Washington DC 20005,

UNITED STATES OF AMERICA

GVOKE VIALDX

Classification Information


Class [005]
Pharmaceutical preparations for in vivo diagnostic use; pharmaceutical preparations for diagnostic radiology use.

Class [044]
Providing information relating to diagnostic properties of pharmaceuticals.

Mark Details


Serial Number

2442128

Registered On

9 Feb 2024

Renewal On

9 Feb 2034

Mark Type

WORD

Priority Claim (Convention Details)


Date

1 Sept 2023

Mark Type

US

Legal History


Show more

Status DateAction Taken
25th Jun 2024International Registration in Australia Protected correspondence sent
24th Jun 2024IP Right Registration Published
24th Jun 2024Status change to Registered/Protected
17th Apr 2024Application Accepted correspondence sent
16th Apr 2024IP Right has been Examined
16th Apr 2024IP Right Acceptance Published
16th Apr 2024Status change to Accepted
15th Apr 2024Examination expedited
15th Apr 2024Awaiting examination
11th Apr 2024IP Right Filed Published